|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Symposia Childhood Brain Tumors |
Departments of Neurology [R.J.P.], Pediatrics [R.J.P.], Neurosurgery [P.C.], and Diagnostic Imaging [G.V.], Children's National Medical Center, Washington, DC 20010; Departments of Neurology [R.J.P.], Pediatrics [R.J.P.], Neurosurgery [P.C.], and Radiology [G.V.], The George Washington University Hospital, Washington, DC 20010; and the Department of Pathology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104 [L.B.R.]
1 Address correspondence and reprint requests to Roger J. Packer, MD, Department of Neurology, Children's National Medical Center, 111 Michigan Avenue, NW, Washington, DC 20010.
Abstract
Medulloblastoma is the most common childhood primary CNS tumor, and treatment approaches have evolved over the past three decades. The biologic under-pinnings of medulloblastoma are not fully characterized, but recent work has identified new, important directions for research. Stratification of patients with medulloblastoma into risk groups is the backbone of most ongoing therapeutic studies. Patients are usually characterized as being either average risk or poor risk, although an intermediate risk group may exist. Standard treatment for older children with medulloblastoma consists of radiation and, for most, chemotherapy. Children with nondisseminated disease at the time of diagnosis have been reported to have as high as an 80% five-year disease-free survival rate after treatment with reduced dose (2340 cGy) craniospinal irradiation, local boost radiation therapy (5500 cGy), and chemotherapy, given during and after radiation therapy. Preradiation chemotherapy has yet to be shown to be of benefit for children with medulloblastoma. Children with disseminated disease are a highly problematic subgroup of patients to treat. A variety of new approaches are being studied, most of which are intensifying chemotherapy either prior to or after radiation. Long-term survivors of medulloblastoma are at significant risk for permanent endocrinologic, cognitive, and psychological sequelae. Infants and very young children with medulloblastoma remain a difficult therapeutic challenge because they have the most virulent form of the disease and are at highest risk for treatment-related sequelae.
References
Allen, J.C., and Epstein, F. (1982) Medulloblastoma and other primary malignant neuroectodermal tumors of the CNS: The effect of patients' age and extent of disease on prognosis. J. Neurosurg. 57,446 -451.[ISI][Medline]
Allen, J.C., and Helson, L. (1981) High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children. J. Neurosurg. 55,749 -756.[Medline]
Allen, J.C., Walker, R.W., Luks, E., Jennings, M., Barfoot, S., and Tan, C. (1987) Carboplatin and recurrent childhood brain tumors. J. Clin. Oncol. 5,459 -463.[Abstract]
Allen, J.C., Donahue, B., DaRosso, R., and Nirenberg, A. (1996) Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors. Int. J. Rad. Oncol. Biol. Phys. 36,1155 -1161.[CrossRef][ISI][Medline]
Ashley, D.M., Meier, L., Kerby, T., Zalduondo, F.M., Friedman,
H.S., Gajjar, A., Kun, L., Duffner, P.K., Smith, S., and Longee, D.
(1996) Response of recurrent medulloblastoma to low-dose oral
etoposide. J. Clin. Oncol.
14,1922
-1927.
Bailey, C.C., Gnekow, A., Wellek, S., Jones, M., Round, C., Brown, J., Phillips, A., and Neidhardt, M.K. (1995) Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma: International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med. Pediatr. Oncol. 25,166 -178.[ISI][Medline]
Baram T.Z., van Eys, J., Dowell, R.E., Cangir, A., Pack, B., and Bruner, J.M. (1987) Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy: A preliminary report. Cancer 60,173 -177.[CrossRef][Medline]
Biegel, J.A., Rorke, L.B., Packer, R.J., Sutton, L.N., Schut, L., Bonner, K., and Emanuel, B.S. (1989). Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer 1, 139-147, 1989.[ISI][Medline]
Bloom, H.I.J., and Bessell, E.M. (1990) Medulloblastoma in adults: A review of 47 patients treated between 1952 and 1981. Int. J. Radiat. Oncol. Biol. Phys. 18,763 -772.[ISI][Medline]
Bunin, G.R., Kuijten, R.R., Buckley, J.D., Rorke, L.B., and
Meadows, A.T. (1993) Relation between maternal diet and
subsequent primitive neuroectodermal brain tumors in young children.
N. Engl. J. Med. 329,536
-541.
Chambers, E.F., Turski, P.A., Sobel, D., Wara, W., and Newton, T.H.
(1981) Radiologic characteristics of primary cerebral
neuroblastomas. Radiology
139,101
-104.
Cogen, P.H., Daneshvar, L., Metzger, A.K., Duyk, G., Edwards, M.S.B., and Sheffield, V.C. (1992). Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am. J. Hum. Gene. 50,581 -589.
Cogen, P.H., and Donahue, J.D. (1999) Approaches to the posterior fossa in children. In: Sekhar, L.N., and de Oliveira, E. (Eds.), Cranial Microsurgery: Approaches and Techniques. New York: Thieme. pp. 399-404.
Cogen, P.H., and McDonald, J.D. (1996). Tumor suppressor genes and medulloblastoma. J. Neurooncol. 29,103 -112.[CrossRef][Medline]
Colt, J.S., and Blair, A. (1998) Parental occupational exposures and risk of childhood cancer. Environ. Health Perspect. 106,909 -925.
Davis, D.G., Wilson, D., Schmitz, M., and Markesbery, W.R. (1993) Lipidized medulloblastoma in adults. Hum. Pathol. 24,990 -995.[Medline]
Deutsch, M., and Reigel, D.H. (1981) Myelography and cytology in the treatment of medulloblastoma. Int. J. Radiat. Oncol. Biol. Phys. 7,721 -725.[Medline]
Deutsch, M., Thomas, P.R., Krischer, J., Boyett, J.M., Albright, L., Aronin, P., Langston, J., Allen, J.C., Packer, R.J., Linggood, R., Mulhern, R., Stanley, P., Stehbens, J.A., Duffner, P., Kun, L., Rorke, L., Cherlow, J., Freidman, H., Finlay, J.L., and Vietti, T. (1996) Results of prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 cGy/13) in patients with low-stage medulloblastoma: A combined Childrens Cancer Group-Pediatric Oncology Group study. Pediatr. Neurosurg. 24,167 -176.[ISI][Medline]
Duffner, P.K., Horowitz, M.E., Krischer, J.P., Friedman, H.S.,
Burger, P.C., Cohen, M.E., Sanford, R.A., Mulhern, R.K., James, H.E., Freeman,
C.R., Seidel, F.C., and Kun, L. (1993) Postoperative chemotherapy
and delayed radiation in children less than three years of age with malignant
brain tumors. N. Eng. J. Med.
328,1725
-1731.
Dupuis-Girod, S., Hartmann, O., Benhamou, E., Doz, F., Mechinaud, F., Bouffet, E., Coze, C., and Kalifa, C. (1996) Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?J. Neurooncol. 27, 87-98.[CrossRef][Medline]
Eibl, R.H., Kleihues, P., Jat, P.S., and Wiestler, O.D. (1994) A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40 large T antigen. Am. J. Pathol. 144,556 -564.[Abstract]
Evans, A.E., Jenkin, R.D., Sposto, R., Ortega, J.A., Wilson, C.B., Wara, W., Ertel, I.J., Kramer, S., Chang, C.H., Leikin, S.L., and Hammond, G.D. (1990) The treatment of medulloblastoma: Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J. Neurosurg. 72,572 -582.[ISI][Medline]
Finlay, J.L., Goldman, S., Wong, M.C., Cairo, M., Garvin, J., August, C., Cohen, B.H., Stanley, P., Zimmerman, R.A., Bostrom, B., Geyer, J.R., Harris, R.E., Sanders, J., Yates, A.J., Boyett, J.M., and Packer, R.J. (1996) Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. J. Clin. Oncol. 14,2495 -2503.[Abstract]
Gajjar, A.J., Heideman, R.L., Douglass, E.C., Kun, L.E., Kovnar,
E.H., Sanford, R.A., Fairclough, D.L., Ayers, D., and Look, A.T.
(1993) Relation of tumorcell ploidy to survival in children with
medulloblastoma. J. Clin. Oncol.
11,2211
-2217.
Gaynon, P.S., Ettinger, L.J., Baum, E.S., Siegel, S.E., Krailo, M.D., and Hammond, G.D. (1990) Carboplatin in childhood brain tumors: A Children's Cancer Study Group phase II trial. Cancer 66,2465 -2469.[CrossRef][Medline]
Geyer, J.R., Zelzer, P.M., Boyett, J.M., Rorke, L.B., Stanley, P.,
Albright, A.L., Wisoff, J.H., Milstein, J.M., Allen, J.C., Finlay, J.L.,
Ayers, G., Shurin, S., Stevens, K., and Bleyer, W.A. (1994)
Survival of infants with primitive neuroectodermal tumors of malignant
ependymomas of the CNS treated with eight-drugs-in-1–day: A report from
the Children's Cancer Group. J. Clin. Oncol.
12,1607
-1615.
Goldwein, J.W., Radcliffe, J., Johnson, J., Moshang, T., Packer, R.J., Sutton, L.N., Rorke, L.B., and D'Angio, G.J. (1996) Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int. J. Rad. Oncol. Biol. Phys. 34,899 -904.[CrossRef][ISI][Medline]
Gould, V.E., Rorke, L.B., Jansson, D.S., Molenaar, W.M., Trojanowski, J.Q., Lee, V.M.-Y., Packer, R.J., and Franke, W.W. (1990a) Primitive neuroectodermal tumors of the central nervous system express neuroendocrine markers and may express all classes of intermediate filaments. Hum. Pathol. 21,245 -252.[CrossRef][ISI][Medline]
Gould, V.E., Jansson, D.S., Molenaar, W.M., Rorke, L.B., Trojanowski, J.Q., Lee, V.M.-Y., Packer, R.J., and Franke, W.W. (1990b) Primitive neuroectodermal tumors of the central nervous system: Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins. Lab. Invest. 62,498 -509.[ISI][Medline]
Graham, M.L., Herndon, J.E. 2nd, Casey, J.R., Chaffee, S., Ciocci,
G.H., Krisher, J.P., Kurtzberg, J., Laughlin, M.J., Longee, D.C., Olsen, J.F.,
Paleologus, N., Pennington, C.N., and Friedman, H.S. (1997)
High-dose chemotherapy with autologous stem-cell rescue in patients with
recurrent and high-risk pediatric brain tumors. J. Clin.
Oncol. 15,1814
-1823.
Hershatter, B.W., Halperin, E.C., and Cox, E.B. (1982) Medulloblastoma: The Duke University Medical Center experience. Int. J. Rad. Oncol. Biol. Phys. 12,1771 -1777.
Janss, A.J., Yachnis, A.T., Silber, J.H., Trojanowski, J.Q., Lee, V.M.-Y., Sutton, L.N., Perilongo, G., Rorke, L.B., and Phillips, P.C. (1996) Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors. Ann. Neurol. 39,481 -489.[CrossRef][ISI][Medline]
Johnson, D.L., McCabe, M.A., Nicholson, H.S., Joseph, A.L., Getson, P.R., Byrne, J., Brasseux, C., Packer, R.J., and Reaman, G. (1994) Quality of long-term survival in young children with medulloblastoma. J. Neurosurg. 80,1004 -1010.[ISI][Medline]
Kalifa, C., Hartmann, O., Demeocq, F., Vassal, G., Couanet, D., Terrier-Lacombe, M.J., Valteau, D., Brugieres, L., and Lemerle, J. (1992) High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: A phase II study. Bone Marrow Transplant. 9, 227-233.[Medline]
Katsetos, C.D., Frankfurter, A., Christakos, S., Mancall, E.L., Viachos, I.N., and Urich, H. (1993) Differential localization of class III, beta-tubulin isotype and calbindin-D28k defines distinct neuronal types in the developing human cerebellar cortex. J. Neuropathol. Exp. Neurol. 52,655 -666.[ISI][Medline]
Kleihues, P., Burger, P.C., and Scheithauer, B.W. (1993) Histological Typing of Tumours of the Central Nervous System. Springer: New York.
Korf, H.-W., Goetz, W., Herken, R., Theuring, F., Gruss, P., and Schachenmayr, W. (1990) S-Antigen and rod-opsin immunoreactions in midline brain neoplasms of transgenic mice: Similarities to pineal cell tumors and certain medulloblastomas in man. J. Neuropathol. Exp. Neurol. 49,424 -437.[ISI][Medline]
Korf, H.-W., Korf, B., Schachenmayr, W., Chader, G.J., and Wiggert, B. (1992) Immunocytochemical demonstration of interphotoreceptor retinoid-binding protein in cerebellar medulloblastoma. Acta. Neuropathol. 83,482 -487.[Medline]
Kovnar, E.H., Kellie, S.J., Horowitz, M.E., Sanford, R.A., Langston, J.W., Mulhern, R.K., Jenkins, J.J., Douglass, E.C., Etcubanas, E.E., Fairclough, D.L., and Kun, L.E. (1990) Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: A phase II study. J. Clin. Oncol. 8,330 -336.[Abstract]
Kuhl, J., Gnekow, A., Havers, W., Lampert, F., Spear, M.J., Maab, E., Grat, N., and Bode, U. (1992) Primary chemotherapy after surgery and delayed irradiation in children under three years of age with medulloblastoma: Pilot trial of the German Pediatric Brain Tumor Study Group. Med. Ped. Oncol. 20,387 . (Abstract)
Kuhl, J., Müller, H.L., Berthold, F., Kortmann, R.-D., Deinlein, F., Maab, E., Graf, N., Gnekow, A., Scheurlen, W., Göbel, U., Wolff, J.E.A., Bamberg, M., Kaatsch, P., Kleihues, P., Rating, D., Sörensen, N., and Wiestler, O.D. (1998) Preradiation chemotherapy of children and young adults with malignant brain tumors: Results of the German pilot trial HIT `88/'89. Klin. Padiatr. 210,227 -233.[ISI][Medline]
Landberg, T.G., Lindgren, M.L., Cavallin-Stahl, E.K., Svahn-Tapper, G.O., Sundbarg, G., Garwicz, S., Lagergren, J.A., Gunnesson, V.L., Brun, A.E., and Cronqvist, S.E. (1980) Improvements in the radiotherapy of medulloblastoma, 1946–1975. Cancer 45,670 -678.[Medline]
Marinesco, G., and Goldstein, M. (1933) Sur une forme anatomique, non encore decrite, de medulloblastome: Medullo-myo-blastome. Ann. Anat. Pathol. 10,513 -525.
Mason, W.P., Grovas, A., Halpern, S., Dunkel, I.J., Garvin, J.,
Heller, G., Rosenblum, M., Gardner, S., Lyden, D., Sands, S., Puccetti, D.,
Lindsley, K., Merchant, T.E., O'Malley, B., Bayer, L., Petriccione, M.M.,
Allen, J., and Finlay, J.L. (1998) Intensive chemotherapy and
bone marrow rescue for young children with newly diagnosed malignant brain
tumors. J. Clin. Oncol.
16,210
-221.
McDonald, J.D., Daneshvar, L., Willert, J.R., Matsumura, K., Waldman, F., and Cogen, P.H. (1994) Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics 23,229 -232.[CrossRef][ISI][Medline]
McIntosh, S., Chen, M., Sartain, P.A., Duncan, C., Fishburn, R., Klatskin, E.H., Schwartz, A.D., and Venes, J.L. (1985) Adjuvant chemotherapy for medulloblastoma. Cancer 56,1316 -1319.[CrossRef][Medline]
Molenaar, W.N., Jansson, D.S., Gould, V.E., Rorke, L.B., Franke, W.W., Lee, V.M.-Y., Packer, R.J., and Trojanowski, J.Q. (1989) Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors: Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors. Lab. Invest. 61,635 -643.[ISI][Medline]
Molenaar, W.M., Rorke, L.B., and Trojanowski, J.Q. (1994) Neuronal tumors. In: Colvin, R.B., Bhan, A.K., and McCluskey, R.T. (Eds.) Diagnostic Immunopathology. Second edition. New York: Raven Press. pp.651 -668.
Mulhern, R.K., Kepner, J.L., Thomas, P.R., Armstrong, F.D., Friedman, H.S., and Kun, L.E. (1998) Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group study. J. Clin. Oncol. 16,1723 -1728.[Abstract]
Nakagawara, A., Arima-Nakagawara, M., Scavarda, N.J, Azar, C.G.,
Cantor, A.B., and Brodeur, G.M. (1993) Association between high
levels of expression of the TRK gene and favorable outcome in human
neuroblastoma. N. Engl. J. Med.
328,847
-854.
Oberfield, S.E., Allen, J.C., Pollack, J., New, M.I., and Levine, L.S. (1986) Longterm endocrine sequelae after treatment of medulloblastoma: Prospective study of growth and thyroid function. J. Pediatr. 108,219 -223.[CrossRef][ISI][Medline]
Olshan, J.S., Gubernick, J., Packer, R.J., D'Angio, G.J., Goldwein, J.W., Willi, S.M., and Moshang, T., Jr. (1992) The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer 70,2013 -2017.[CrossRef][ISI][Medline]
Packer, R.J (1990) Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa. Ann. Neurol. 28,823 -828.[CrossRef][Medline]
Packer, R.J., Deutsch, M., Thomas, P.R.M., Boyett, J., Kun, L., and Friedman, H. (1996) What constitutes standard therapy for children older than 3 years of age with non-disseminated medulloblastoma. Ann. Neurol. 40,292 -293.
Packer, R.J., Geyer, R., Jennings, M., Boyett, J., Ater, J., Axtell, R., Breiger, D., Donohue, B., Finlay, J., Goldwin, J., Meier, L., Johnson, D., Maczewski, C., Miller, D., Neuberg, R., Pucetti, D., Raffel, C., Radcliffe, J., Shiminski-Maher, T., and Zelter, P. (1998) Disease control in infants and young children with medulloblastomas and ependymomas using chemotherapy alone: A Children's Cancer Group study. Ann. Neurol. 44,537 .
Packer, R.J., Siegel, K.R., Sutton, L.N., Evans, A.E., D'Angio, G., Rorke, L.B., Bunin, G.R., and Schut, L. (1988) Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: A preliminary report. Ann. Neurol. 24,503 -508.[CrossRef][ISI][Medline]
Packer, R.J., Sutton, L.N., Atkins, T.E., Radcliffe, J., Bunin, G.R., D'Angio, G.J., Siegel, K.R., and Schut, L. (1989) A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: 2–Year results. J. Neurosurg. 70,707 -713.[ISI][Medline]
Packer, R.J., Sutton, L.N., Elterman, R., Lange, B., Goldwein, J., Nicholson, H.S., Mulne, L., Boyett, J., D'Angio, G., Wechsler-Jentzsch, K., Reaman, G., Cohen, B., Bruce, D.A., Rorke, L.B., Malloy, P., Ryan, J., LaFond, D., Evans, E., and Schut, L. (1994) Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J. Neurosurg. 81,690 -698.[ISI][Medline]
Packer, R.J., Sutton, L.N., Rorke, L.B., Littman, P.A., Sposto, R., Rosenstock, J.G., Bruce, D.A., and Schut, L. (1984) Prognostic importance of cellular differentiation in medulloblastoma of childhood. J. Neurosurg. 61,296 -301.[ISI][Medline]
Pearl, G.S., and Takei, Y. (1981) Cerebellar "neuroblastoma." Nosology as it relates to medulloblastoma. Cancer 47,772 -779.[CrossRef][Medline]
Pendergrass, T.W., Milstein, J.M., Geyer, J.R., Mulne, A.F.,
Kosnik, E.J., Morris, J.D., Heideman, R.L., Ruymann, F.B., Stuntz, J.T., and
Bleyer, W.A. (1987) Eight drugs in one day chemotherapy for brain
tumors: Experience in 107 children and rationale for preradiation
chemotherapy. J. Clin. Oncol.
5,1221
-1231.
Pollack, I.F., Polinko, P., Albright, A.L., Towbin, R., and Fitz, C. (1995) Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: Incidence and pathophysiology. Neurosurgery 37,885 -893.[ISI][Medline]
Prados, M.D., Wara, W.M., Edwards, M.S.B., and Cogen, P.H. (1994) Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: Early results of a pilot study. Int. J. Rad. Oncol. Biol. Phys. 28,431 -438.[ISI][Medline]
Radcliffe, J., Packer, R.J., Atkins, T.E., Bunin, G.R., Schut, L., Goldwein, J.W., and Sutton, L.N. (1992) Three- and four-year cognitive outcome in children with noncortical brain tumors treated with whole-brain radiotherapy. Ann. Neurol. 32,551 -554.[CrossRef][ISI][Medline]
Reardon, D.A., Michalkiewicz, E., Boyett, J.M., Sublett, J.E.,
Entrekin, R.E., Ragsdale, S.T., Valentine, M.B., Behm, F.G., Li, H., Heideman,
R.L., Kun, L.E., Shapiro, D.N., and Look, A.T. (1997) Extensive
genomic abnormalities in childhood medulloblastoma by comparative genomic
hybridization. Cancer Res.
57,4042
-4047.
Rorke, L.B. (1983) The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J. Neuropathol. Exp. Neurol. 42,1 -15.[ISI][Medline]
Rorke, L.B. (1994) Introductory survey of brain tumors. In: Cheek, W.R., Marlin, A.E., McLone, D.G., Reigel, D.H., and Walker, M.L. (Eds.), Pediatric Neurosurgery: Surgery of the Developing Nervous System. Third edition. Philadelphia: W.B. Saunders Company, pp. 351-355.
Rorke, L.B., Gilles, F.H., Davis, R.L., and Becker, L.E. (1985) Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 56 (Suppl. 7),1869 -1886.[CrossRef][ISI][Medline]
Rorke, L.B., Packer, R.J., and Biegel, J.A. (1996) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: Definition of an entity. J. Neurosurg. 85, 56-65.[ISI][Medline]
Rorke, L.B., Trojanowski, J.Q., Lee, V.M.-Y., Zimmerman, R.A., Sutton, L.N., Biegel, J.A., Goldwein, J.W., and Packer, R.J. (1997) Primitive neuroectodermal tumors of the central nervous system. Brain Pathol. 7,765 -784.[ISI][Medline]
Rubinstein, L.J. (1970) The definition of the ependymoblastoma. Arch. Pathol. 90, 35-45.[Medline]
Sandhu, A., and Kendall, B. (1987) Computed tomography in management of medulloblastomas. Neuroradiology 29,444 -452.[CrossRef][ISI][Medline]
Scheurlen, W.G., Schwabe, G.C., Joos, S., Mollenhauer, J., Sörensen, N., and Kühl, J. (1998) Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. J. Clin. Oncol. 16,2478 -2485.[Abstract]
Segal, R.A., Goumnerova, L.C., Kwon, Y.K., Stiles, C.D., and
Pomeroy, S.L. (1994) Expression of the neurotrophin receptor TrkC
is linked to a favorable outcome in medulloblastoma. Proc. Natl.
Acad. Sci. U. S. A. 91,12867
-12871.
Sexauer, C.L., Khan, A., Burger, P.C., Krishner, J.P., Van Eyes, J., Vats, T., and Ragab, A.H. (1985) Cisplatin in recurrent pediatric brain tumors: A POG phase II study. Cancer 56,1497 -1501.[CrossRef][Medline]
Shalet, S.M., Beardwell, C.G., Twomey, J.A., Jones, P.H., and Pearson, D. (1977) Endocrine function following the treatment of acute leukemia in childhood. J. Pediatr. 90,920 -923.[CrossRef][ISI][Medline]
Shalet, S.M., Gibson, B., Swindell, R., and Pearson, D. (1987) Effect of spinal irradiation on growth. Arch. Dis. Child. 62,461 -464.[Abstract]
Silber, J.H., Littman, P.S., and Meadows, A.T. (1990) Stature loss following skeletal irradiation for childhood cancer. J. Clin. Oncol. 8,304 -312.[Abstract]
Soylemezoglu, F., Soffer, D., Onol, B., Schwechheimer, K., and Kleihues, P. (1996) Lipomatous medulloblastoma in adults: A distinct clinicopathological entity. Am. J. Surg. Pathol. 20,413 -418.[Medline]
Tait, D.M., Thornton-Jones, H., Bloom, H.J., Lemerle, J., and Morris-Jones, P. (1990) Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur. J. Cancer 26,464 -469.
Thomas, G.A., and Raffel, C. (1991) Loss of
heterozygosity on 6q, 16q, and 17p in human central nervous system primitive
neuroectodermal tumors. Cancer Res.
51,639
-643.
Thomas, P.R., Deutsch, M., Mulhern, R., Stehbens, J., Krishner, J.P., Boyett, J.M., Shuster, J.J., Linggood, R.M., Kun, L., Finlay, J., Friedman, G.D., Packer, R.J., Aronin, P.A., Albright, L.A., Viette, T.J., and Hammond, G.D. (1995) Reduced dose vs standard dose neuraxis irradiation in low stage medulloblastoma: The POG and CCG study. Med. Pediatr. Oncol. 24,277 . (Abstract)
Vezina, L.G., and Packer, R.J. (1994) Infratentorial brain tumors of childhood. Neuroimaging Clin. N. Am. 4, 423-436.[Medline]
Xie, J., Johnson, R.L., Zhang, X., Bare, J.W., Waldman, F.M.,
Cogen, P.H., Menon, A.G., Warren, R.S., Chen, L.-C., Scott, M.P., and Epstein,
E.H. (1997). Mutations of the PATCHED gene in several types of
sporadic extracutaneous tumors. Cancer Res.
57,2369
-2372.
Yagishita, S., Itoh, Y., Chiba, Y., Yamashita, T., Nakazima, F., and Kuwabara, T. (1980) Cerebellar neuroblastoma: A light and ultrastructural study. Acta. Neuropathol. 50,139 -142.[Medline]
Zahm, S.H., and Ward, M.H. (1998) Pesticides and childhood cancer. Environ. Health Perspect. 106 (Suppl. 3),893 -908.
Zeltzer, P., Boyett, J., Finlay, J.L., Albright, L., Wisoff, J., Geyer, R., McGuire-Cullen, P., Rorke, L.B., Stevens, K., Shurin, S., Milstein, J., and Packer, R.J. (1995) Tumor staging at diagnosis and therapy type for PNET determine survival. Report from the Children's Cancer Group CCG-921. Med. Pediatr. Oncol. 25, 238. (Abstract)
Zerbini, C., Gelber, R.D., Weinberg, D., Sallan, S.E., Barnes, P., Kupsky, W., Scott, R.M., and Tarbell, N.J. (1993) Prognostic factors in medulloblastoma, including DNA ploidy. J. Clin. Oncol. 11,616 -622.[Abstract]
Zimmerman, R.A., Bilaniuk, L.T., and Pahlajani, H. (1978) Spectrum of medulloblastomas demonstrated by computed tomography. Radiology 126,137 -141.[Abstract]
Zimmerman, R.A., Bilaniuk, L.T., and Rebsamen, S. (1992) Magnetic resonance imaging of pediatric posterior fossa tumors. Pediatr. Neurosurg. 18, 58-64.[ISI][Medline]
This article has been cited by other articles:
|
|
 |
|
  R. J. Packer Childhood Brain Tumors: Accomplishments and Ongoing Challenges J Child Neurol, October 1, 2008; 23(10): 1122 - 1127. [Abstract] [PDF]
|
|
|
|
|
|
F. Nejat, M. El Khashab, and J. T. Rutka Initial Management of Childhood Brain Tumors: Neurosurgical Considerations J Child Neurol, October 1, 2008; 23(10): 1136 - 1148. [Abstract] [PDF]
|
|
|
|
|
|
T. J. MacDonald Aggressive Infantile Embryonal Tumors J Child Neurol, October 1, 2008; 23(10): 1195 - 1204. [Abstract] [PDF]
|
|
|
|
 |
|
 S. R. Parathath, L. A. Mainwaring, A. Fernandez-L, D. O. Campbell, and A. M. Kenney Insulin receptor substrate 1 is an effector of sonic hedgehog mitogenic signaling in cerebellar neural precursors Development, October 1, 2008; 135(19): 3291 - 3300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Vibhakar, G. Foltz, J.-g. Yoon, L. Field, H. Lee, G.-y. Ryu, J. Pierson, B. Davidson, and A. Madan Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma Neuro-oncol, April 1, 2007; 9(2): 135 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Bar, A. Chaudhry, M. H. Farah, and C. G. Eberhart Hedgehog Signaling Promotes Medulloblastoma Survival via BclII Am. J. Pathol., January 1, 2007; 170(1): 347 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-K. Kim, S. U. Kim, I. H. Park, J. H. Bang, K. S. Aboody, K.-C. Wang, B.-K. Cho, M. Kim, L. G. Menon, P. M. Black, et al. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin. Cancer Res., September 15, 2006; 12(18): 5550 - 5556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Packer, A. Gajjar, G. Vezina, L. Rorke-Adams, P. C. Burger, P. L. Robertson, L. Bayer, D. LaFond, B. R. Donahue, M. H. Marymont, et al. Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma J. Clin. Oncol., September 1, 2006; 24(25): 4202 - 4208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Hatton, P. S. Knoepfler, A. M. Kenney, D. H. Rowitch, I. M. de Alboran, J. M. Olson, and R. N. Eisenman N-myc Is an Essential Downstream Effector of Shh Signaling during both Normal and Neoplastic Cerebellar Growth. Cancer Res., September 1, 2006; 66(17): 8655 - 8661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Hallahan, J. I. Pritchard, S. Hansen, M. Benson, J. Stoeck, B. A. Hatton, T. L. Russell, R. G. Ellenbogen, I. D. Bernstein, P. A. Beachy, et al. The SmoA1 Mouse Model Reveals That Notch Signaling Is Critical for the Growth and Survival of Sonic Hedgehog-Induced Medulloblastomas Cancer Res., November 1, 2004; 64(21): 7794 - 7800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xu, A. Janss, and T. Moshang Adult Height and Adult Sitting Height in Childhood Medulloblastoma Survivors J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4677 - 4681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Packer, J. G. Gurney, J. A. Punyko, S. S. Donaldson, P. D. Inskip, M. Stovall, Y. Yasui, A. C. Mertens, C. A. Sklar, H. S. Nicholson, et al. Long-Term Neurologic and Neurosensory Sequelae in Adult Survivors of a Childhood Brain Tumor: Childhood Cancer Survivor Study J. Clin. Oncol., September 1, 2003; 21(17): 3255 - 3261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gururangan, C. McLaughlin, J. Quinn, J. Rich, D. Reardon, E. C. Halperin, J. Herndon II, H. Fuchs, T. George, J. Provenzale, et al. High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Children and Adults With Newly Diagnosed Pineoblastomas J. Clin. Oncol., June 1, 2003; 21(11): 2187 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. MacDonald, B. R. Rood, M. R. Santi, G. Vezina, K. Bingaman, P. H. Cogen, and R. J. Packer Advances in the Diagnosis, Molecular Genetics, and Treatment of Pediatric Embryonal CNS Tumors Oncologist, April 1, 2003; 8(2): 174 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Geoerger, K. Kerr, C.-B. Tang, K.-M. Fung, B. Powell, L. N. Sutton, P. C. Phillips, and A. J. Janss Antitumor Activity of the Rapamycin Analog CCI-779 in Human Primitive Neuroectodermal Tumor/Medulloblastoma Models as Single Agent and in Combination Chemotherapy Cancer Res., February 1, 2001; 61(4): 1527 - 1532. [Abstract] [Full Text]
|
|
|
|
|
|
R. J. Packer, J. M. Boyett, A. J. Janss, T. Stavrou, L. Kun, J. Wisoff, C. Russo, R. Geyer, P. Phillips, M. Kieran, et al. Growth Hormone Replacement Therapy in Children With Medulloblastoma: Use and Effect on Tumor Control J. Clin. Oncol., January 15, 2001; 19(2): 480 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Biegel, B. Fogelgren, J.-Y. Zhou, C. D. James, A. J. Janss, J. C. Allen, D. Zagzag, C. Raffel, and L. B. Rorke Mutations of the INI1 Rhabdoid Tumor Suppressor Gene in Medulloblastomas and Primitive Neuroectodermal Tumors of the Central Nervous System Clin. Cancer Res., July 1, 2000; 6(7): 2759 - 2763. [Abstract] [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
